Biotech / MedTech

Prenetics, which is expected to go public on the Nasdaq in the first quarter of next year, is also actively looking for local partners in Southeast Asia.

RWDC Industries Limited announced the closing of a $95.1 million Series B2 funding round co-led by Singapore venture capital firm Vickers Venture Partners and Singapore state investor Temasek. The funding will support the group’s expansion and boost its production of biodegradable biopolymer material that will help the group speed adoption of sustainable…

Turtle Tree has successfully raised $30 million in the first tranche of its Series A funding, one of the largest investment rounds to date in Asia's cell-based food sector. The funding sees participation from investors worldwide, including lead investor VERSO Capital. Following this round of funding, TurtleTree has now raised over US$40 million to date.

Led by CR-CP Life Science Fund, this new capital will support MiRXES’s growth as a global leader in cancer early detection tests and preventive healthcare.

Proceeds from the funding will be used to progress Insilico Medicine's current therapeutic programs into human clinical trials, initiate multiple new programs for novel and difficult targets, and further develop its AI and drug discovery capabilities, the company added. 

Fresh capital will be used to expand in other Asia-Pacific countries such as Indonesia, Malaysia, India, and the Philippines and improve the platform to include new features based on accelerated demand driven by the pandemic. 

Tokyo-based DCI Partners, a venture fund manager of Daiwa Securities Group, has announced the launch of Daiwa Taiwan-Japan BioVenture Investment Limited Partnership II, a $135 million (JPY 14 billion) investment fund intended for drug discovery.